The Israel industry was valued at USD 534.0 million in 2025.
Our projections suggest that the Israel Infusion Services Market will reach USD 1.25 billion by 2033, registering a CAGR of 11.2% during the forecast period.
Highly advanced public health infrastructure supports broad biologic access, with infusion services concentrated in tertiary academic medical centers.
Israel Ministry of Health cancer registry statistics demonstrate stable treated case volumes, maintaining predictable systemic therapy activity.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]